Clinical Trial Update: Noninvasive Evaluation of Cardiac Allograft Vasculopathy

View source ↗

Summary

A clinical trial evaluating noninvasive evaluation of cardiac allograft vasculopathy was withdrawn by the sponsor, University of Minnesota.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Snippet

Sponsor: University of Minnesota | Conditions: Cardiac Allograft Vasculopathy | Status: WITHDRAWN